Disclaimer

RIBAVIRIN (ORAL) AND INTERFERON ALPHA-2B (INJECTION), Rebetron

GENERIC NAME: RIBAVIRIN (ORAL) AND INTERFERON ALPHA-2B (INJECTION) (rye-buh-VYE-rin/in-ter-FEER-on)

BRAND NAME(S): Rebetron

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage | Medical Alert

WARNING: Because the ribavirin in this combination product has cause birth defects and fetal death, it must not be used during pregnancy. Men and women of childbearing potential must avoid pregnancy and use 2 forms of effective birth control (contraception) during treatment with this product and for 6 months after this medication has been stopped. The interferon can cause or worsen some serious medical conditions including psychiatric conditions (e.g., depression), immune system problems (autoimmune conditions such as lupus or rheumatoid arthritis), circulation problems (e.g., cardiovascular disease/blood clots), or infections (bone marrow suppression). If your medical history includes these conditions, inform your doctor promptly. Also, tell your doctor immediately if any serious symptoms or side effects occur (see Side Effects section). These conditions occur infrequently, but some can be fatal.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright

STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!